121 related articles for article (PubMed ID: 32521914)
41. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.
Papini E; Guglielmi R; Bianchini A; Crescenzi A; Taccogna S; Nardi F; Panunzi C; Rinaldi R; Toscano V; Pacella CM
J Clin Endocrinol Metab; 2002 May; 87(5):1941-6. PubMed ID: 11994321
[TBL] [Abstract][Full Text] [Related]
42. Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
Chung SR; Baek JH; Park HS; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
Thyroid; 2017 May; 27(5):707-713. PubMed ID: 28326900
[TBL] [Abstract][Full Text] [Related]
43. Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?
Gweon HM; Son EJ; Youk JH; Kim JA
Ann Surg Oncol; 2013 Sep; 20(9):3083-8. PubMed ID: 23700214
[TBL] [Abstract][Full Text] [Related]
44. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
45. The Implementation of the Bethesda System for Reporting Thyroid Cytopathology Improves Malignancy Detection Despite Lower Rate of Thyroidectomy in Indeterminate Nodules.
Hirsch D; Robenshtok E; Bachar G; Braslavsky D; Benbassat C
World J Surg; 2015 Aug; 39(8):1959-65. PubMed ID: 25809059
[TBL] [Abstract][Full Text] [Related]
46. Significance of ultrasound features in predicting malignant solid thyroid nodules: need for fine-needle aspiration.
Yunus M; Ahmed Z
J Pak Med Assoc; 2010 Oct; 60(10):848-53. PubMed ID: 21381618
[TBL] [Abstract][Full Text] [Related]
47. Factors that Influence Sample Adequacy in Liquid-Based Cytology after Ultrasonography-Guided Fine-Needle Aspiration of Thyroid Nodules: A Single-Center Study.
Lee YJ; Kim DW; Jung SJ; Baek HJ
Acta Cytol; 2018; 62(4):253-258. PubMed ID: 29393083
[TBL] [Abstract][Full Text] [Related]
48. Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules.
Weiss VL; Andreotti RF; Ely KA
Cancer Cytopathol; 2018 Aug; 126(8):518-524. PubMed ID: 29733503
[TBL] [Abstract][Full Text] [Related]
49. Size and Ultrasound Features Affecting Results of Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules.
Dong Y; Mao M; Zhan W; Zhou J; Zhou W; Yao J; Hu Y; Wang Y; Ye T
J Ultrasound Med; 2018 Jun; 37(6):1367-1377. PubMed ID: 29120064
[TBL] [Abstract][Full Text] [Related]
50. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
51. Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations.
Hodax JK; Bowerman K; Quintos JB
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):895-901. PubMed ID: 31271555
[TBL] [Abstract][Full Text] [Related]
52. Malignancy risk stratification in thyroid nodules with benign results on cytology: combination of thyroid imaging reporting and data system and Bethesda system.
Moon HJ; Kim EK; Kwak JY
Ann Surg Oncol; 2014 Jun; 21(6):1898-903. PubMed ID: 24558069
[TBL] [Abstract][Full Text] [Related]
53. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
Lew JI; Snyder RA; Sanchez YM; Solorzano CC
J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
[TBL] [Abstract][Full Text] [Related]
54. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study.
Espinosa De Ycaza AE; Lowe KM; Dean DS; Castro MR; Fatourechi V; Ryder M; Morris JC; Stan MN
Thyroid; 2016 Nov; 26(11):1598-1604. PubMed ID: 27549368
[TBL] [Abstract][Full Text] [Related]
55. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules.
Alexander EK; Heering JP; Benson CB; Frates MC; Doubilet PM; Cibas ES; Marqusee E
J Clin Endocrinol Metab; 2002 Nov; 87(11):4924-7. PubMed ID: 12414851
[TBL] [Abstract][Full Text] [Related]
56. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
57. Examining the Bethesda criteria risk stratification of thyroid nodules.
Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
[TBL] [Abstract][Full Text] [Related]
58. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
59. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
60. Suspicious sonographic and cytological findings in patients with subacute thyroiditis: Two case reports.
Park HK; Kim DW; Lee YJ; Ha TK; Kim DH; Bae SK; Jung SJ
Diagn Cytopathol; 2015 May; 43(5):399-402. PubMed ID: 25350937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
